Novel benzyl pyrimidines
作者： Rudolf Then , Henri Stalder , Raffaello Masciadri , Philippe Guerry , Synese Jolidon
DOI:
关键词:
摘要: Substituted 5-benzyl-2,4-diaminopyrimidines of general formula (I) in which R1 represents lower alkoxy, R2 bromine or alkoxy and R3 aryl, heteroaryl a group -Q-R30, wherein Q signifies ethylene, vinylene ethynylene R30 heteroaryl, alkoxy-carbonyl carbamoyl, as well readily hydrolyzable esters carboxylic acids I pharmaceutically acceptable salts these compounds can be used the control prevention infectious diseases.
lens.org 参考文章(5)
R. L. Then, P. G. Hartman, I. Kompis, D. Santi, Selective Inhibition of Dihydrofolate Reductase from Problem Human Pathogens Advances in Experimental Medicine and Biology. ,vol. 338, pp. 533- 536 ,(1993) , 10.1007/978-1-4615-2960-6_108
Barbara Roth, Mary Y. Tidwell, Robert Ferone, David P. Baccanari, Carl W. Sigel, Diane DeAngelis, Lynn P. Elwell, 2,4-Diamino-5-benzylpyrimidines as antibacterial agents. 13. Some alkenyl derivatives with high in vitro activity against anaerobic organisms. Journal of Medicinal Chemistry. ,vol. 32, pp. 1949- 1958 ,(1989) , 10.1021/JM00128A043
Ivan Kompis, Guido Zanetti, Gerald Rey-Bellet, 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines ,(1981)
Jeffrey M. Blaney, Ivan Kompis, Charles K. Marlow, Specific inhibition of dihydrofolate reductase and compounds therefor ,(1991)
Tetsushi c, Tomio c, Aminoquinolone derivatives as anti-HIV agents ,(1993)